glp-1 vision Medications and Your Lipsitz, Ponterio & Comerford |
Description
Anam M, Maharjan S, Amjad Z, et al
PMID: 14149200
Group UKMS
Morgan Healthcare Conference in San Francisco, California
An N-terminal fragment of GLP-1, corresponding to GLP-1(7-17) but with Val 16 and Ser 17 substituted with biphenylalanine derivatives, displayed potency that was only 206-fold lower than GLP-1 itself (Mapelli et al ., 2009)
